As a deubiquitinating enzyme, USP13 exhibits both tumor-promoting and tumor-suppressing effects and is related to the initiation, progression, and apoptosis of breast, bladder, and ovarian cancers and other tumors [12,13,17,28]. Here, USP13 is linked to ovarian cancer.